WHO: Genomic Studies Skewed to Rich Nations, Under 5% in LMICs

A new WHO report reveals that less than 5% of disease-focused genomic studies occur in low and middle-income countries, while over 80% are concentrated in high-income nations. This disparity threatens global health equity, limiting benefits for populations most in need, including India.

• Under 5% of genomic studies are conducted in low and middle-income countries.
• Over 80% of global genomic research is concentrated in high-income nations.
• India features among top 20 countries in studies but rarely leads.
• Cancer and rare diseases dominate research; infectious diseases are underrepresented.
• The WHO urges global action for equitable access and investment in LMICs.
• The report covers over 6,500 studies from 1990-2024, highlighting stark inequities.

Read the full story on Quick Digest.